MYIFX
Price
$20.28
Change
-$0.00 (-0.00%)
Updated
Sep 20 closing price
RGAHX
Price
$75.98
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

MYIFX vs RGAHX

Header iconMYIFX vs RGAHX Comparison
Open Charts MYIFX vs RGAHXBanner chart's image
Monetta Young Investor Growth
Price$20.28
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$75.98
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MYIFX vs RGAHX Comparison Chart
Loading...
VS
MYIFX vs. RGAHX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYIFX is a StrongBuy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 290B vs. MYIFX (40.2M). RGAHX pays higher dividends than MYIFX: RGAHX (0.64) vs MYIFX (0.00). MYIFX was incepted earlier than RGAHX: MYIFX (18 years) vs RGAHX (9 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. MYIFX (6.20). RGAHX has a lower initial minimum investment than MYIFX: RGAHX (250) vs MYIFX (1000). RGAHX annual gain was more profitable for investors over the last year : 30.34 vs. MYIFX (22.98). RGAHX return over 5 years is better than : 54.03 vs. MYIFX (-9.96).
MYIFXRGAHXMYIFX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years9 years-
Gain YTD18.94421.86087%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets40.2M290B0%
Annual Yield % from dividends0.000.64-
Returns for 1 year22.9830.3476%
Returns for 3 years-10.380.79-1,321%
Returns for 5 years-9.9654.03-18%
Returns for 10 years0.07N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPTA8.760.16
+1.86%
Perpetua Resources Corp
YHGJ1.010.01
+1.01%
Yunhong Green CTI Ltd
ARQT10.150.01
+0.10%
Arcutis Biotherapeutics
MATX134.72-2.46
-1.79%
Matsons
CSGP77.36-1.93
-2.43%
CoStar Group